You have 9 free searches left this month | for more free features.

PCWG3

Showing 426 - 434 of 434

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Metastatic Trial in Worldwide (EMD 525797, Placebo, Standard of Care (SoC))

Completed
  • Prostate Cancer Metastatic
  • EMD 525797
  • +2 more
  • Pleasant Hill, California
  • +70 more
Nov 9, 2015

Prostate Cancer Trial in Japan (Abiraterone, Prednisolone)

Completed
  • Prostate Cancer
  • Asahi, Japan
  • +17 more
Nov 3, 2015

Prostatic Tumors Trial in Trento (Docetaxel, Prednisone, Enzalutamide)

Unknown status
  • Prostatic Neoplasms
  • Trento, Italy
    Santa Chiara Hospital
May 22, 2015

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Cleveland (linsitinib,

Completed
  • Adenocarcinoma of the Prostate
  • +3 more
  • Cleveland, Ohio
  • +1 more
Mar 2, 2015

Castration-resistant Prostate Cancer, Advanced Breast Cancer Trial in Nagoya-city, Kobe-city, Chuo-ku (LFA102)

Completed
  • Castration-resistant Prostate Cancer, Advanced Breast Cancer
  • Nagoya-city, Aichi, Japan
  • +2 more
Nov 9, 2014

Metastatic Castrate-Resistant Prostate Cancer (mCRPC),, Efficacy,, Safety and Tolerability, Trial in United Kingdom, United

Completed
  • Metastatic Castrate-Resistant Prostate Cancer (mCRPC),
  • +5 more
  • Intermittent dosing of AZD5363
  • Sarasota, Florida
  • +7 more
Jun 18, 2014

Prostatic Tumor Trial in New York, Sutton (EZN-4176)

Suspended
  • Prostatic Neoplasm
  • New York, New York
  • +1 more
Dec 17, 2012

Prostate Cancer Trial in United States (Tesetaxel)

Unknown status
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +3 more
Jul 20, 2012